Lion Street Advisors LLC Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lion Street Advisors LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 990 shares of the medical equipment provider’s stock after selling 44 shares during the quarter. Lion Street Advisors LLC’s holdings in Intuitive Surgical were worth $517,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. Bennett Selby Investments LP raised its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC grew its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. raised its stake in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Journey Strategic Wealth LLC lifted its holdings in shares of Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after acquiring an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $579.65 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm’s 50-day simple moving average is $551.99 and its two-hundred day simple moving average is $512.04. The stock has a market cap of $206.46 billion, a PE ratio of 90.43, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 in the last 90 days. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ISRG shares. Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Royal Bank of Canada increased their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. BTIG Research lifted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.